Skip to main content

Canton Barry's Form 4 filing

Ginkgo Bioworks Holdings, Inc. (DNA) · filed Feb 2, 2023

Accession no.
0001127602-23-003181
Filed
Feb 2, 2023
Trade date
Jan 31-Feb 1, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions. Open-market sales total $1.22M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Canton BarryCIK 000188275610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 31, 2023Class A Common StockSSaleDisposed−149,554$1.85−$276,674.914,893,808Direct
Jan 31, 2023Class A Common StockSSaleDisposed−149,554$1.85−$276,674.914,893,820Indirect
Feb 1, 2023Class A Common StockSSaleDisposed−154,910$1.91−$295,878.114,738,898Direct
Feb 1, 2023Class A Common StockSSaleDisposed−37,650$1.93F3−$72,664.514,856,170Indirect
Feb 1, 2023Class A Common StockSSaleDisposed−154,910$1.91−$295,878.114,701,260Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)